Back to IMVT
TCG Crossover Management, LLC → IMVT
TCG Crossover Management, LLC IMVT Position History
Immunovant, Inc. • Healthcare
Quarters held
4
Latest value
$150.6M
Q3 2026
Peak value
$171.8M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $42.2M |
| Q1 2026 | $110.7M |
| Q2 2026 | $171.8M |
| Q3 2026 | $150.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $150.6M | 4.46M | — | — |
| Q2 2026 | $171.8M | 4.46M | — | — |
| Q1 2026 | $110.7M | 4.46M | — | — |
| Q4 2025 | $42.2M | 1.66M | — | — |
Other funds holding IMVT
$359.9M
$347.2M
$309.5M
$290.6M
$286.3M
$275.5M
$246.8M
Other TCG Crossover Management, LLC positions
AAVXF
$959MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$800.6MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$721.7MABIVAX SA AMERICAN DEPOSITARY SHARES
AAVXF
$362.7MABIVAX SA AMERICAN DEPOSITARY SHARES
TNGX
$283.9MTANGO THERAPEUTICS INC
CGON
$260.8MCG ONCOLOGY INC
CGON
$260.2MCG ONCOLOGY INC
CGON
$248.4MCG ONCOLOGY INC